aTyr Pharma

ATYR PHARMA INC

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

aTyr Pharma Inc

News

Health Care

Press Releases

aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody ATYR2810 at the American Association for Cancer Research (AACR) Annual Meeting 2025

Biotech

Earnings

General

aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update

aTyr Pharma Advances ATYR0101 to IND Candidate Stage for Pulmonary Fibrosis

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Presents Three Posters on Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference

aTyr Pharma to Present at Upcoming Investor Conferences

aTyr Pharma Announces Findings from Interim Analysis of Ongoing Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)

aTyr Pharma to be Added to the Russell 2000® and Russell 3000® Indexes

aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis

aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update

ATYR

Absci

AnaptysBio

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Emergent BioSolutions

Erasca

Gossamer Bio

ITeos Therapeutics

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Myriad Genetics

Nanobiotix

Prothena Corporation plc - Ordinary Shares

Prothena Corp

PureTech Health plc - American Depositary Shares

PureTech Health

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Replimune Group

Regenxbio

Rezolute

Solid Biosciences

Savara

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tourmaline Bio

Verastem

Xencor

Wells Fargo

HC Wainwright & Co.

Leerink Partners

Jefferies

RBC Capital

Comments

aTyr Pharma

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL